This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Earnshaw, D L
Right arrow Articles by Vere Hodge, R A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Earnshaw, D L
Right arrow Articles by Vere Hodge, R A

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 December; 36(12): 2747-2757

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.

D L Earnshaw, T H Bacon, S J Darlison, K Edmonds, R M Perkins and R A Vere Hodge

SmithKline Beecham Pharmaceuticals, Epsom, Surrey, England.

ABSTRACT

The metabolism and mode of action of penciclovir [9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; BRL 39123] were studied and compared with those of acyclovir. In uninfected MRC-5 cells, low concentrations of the triphosphates of penciclovir and acyclovir were occasionally just detectable, the limit of detection being about 1 pmol/10(6) cells. In contrast, in cells infected with either herpes simplex virus type 2 (HSV-2) or varicella-zoster virus (VZV), penciclovir was phosphorylated quickly to give high concentrations of the triphosphate ester. Following the removal of penciclovir from the culture medium, penciclovir-triphosphate remained trapped within the cells for a long time (half-lives, 20 and 7 h in HSV-2- and VZV-infected cells, respectively). In HSV-2-infected cells, acyclovir was phosphorylated to a lesser extent and the half-life of the triphosphate ester was only 1 h. We were unable to detect any phosphates of acyclovir in VZV-infected cells. (S)-Penciclovir-triphosphate inhibited HSV-1 and HSV-2 DNA polymerase competitively with dGTP, the Ki values being 8.5 and 5.8 microM, respectively, whereas for acyclovir-triphosphate, the Ki value was 0.07 microM for the two enzymes. Both compounds had relatively low levels of activity against the cellular DNA polymerase alpha, with Ki values of 175 and 3.8 microM, respectively. (S)-Penciclovir-triphosphate did inhibit DNA synthesis by HSV-2 DNA polymerase with a defined template-primer, although it was not an obligate chain terminator like acyclovir-triphosphate. These results provide a biochemical rationale for the highly selective and effective inhibition of HSV-2 and VZV DNA synthesis by penciclovir and for the greater activity of penciclovir than that of acyclovir when HSV-2-infected cells were treated for a short time.

Antimicrob Agents Chemother. 1992 December; 36(12): 2747-2757




This article has been cited by other articles:

  • Green, L. A., Nguyen, K., Berenji, B., Iyer, M., Bauer, E., Barrio, J. R., Namavari, M., Satyamurthy, N., Gambhir, S. S. (2004). A Tracer Kinetic Model for 18F-FHBG for Quantitating Herpes Simplex Virus Type 1 Thymidine Kinase Reporter Gene Expression in Living Animals Using PET. JNM 45: 1560-1570 [Abstract] [Full Text]  
  • Suzutani, T., Ishioka, K., De Clercq, E., Ishibashi, K., Kaneko, H., Kira, T., Hashimoto, K.-i., Ogasawara, M., Ohtani, K., Wakamiya, N., Saijo, M. (2003). Differential Mutation Patterns in Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus Type 1 Clones Passaged in the Presence of Acyclovir or Penciclovir. Antimicrob. Agents Chemother. 47: 1707-1713 [Abstract] [Full Text]  
  • Luker, G. D., Sharma, V., Pica, C. M., Prior, J. L., Li, W., Piwnica-Worms, D. (2003). Molecular Imaging of Protein-Protein Interactions: Controlled Expression of p53 and Large T-Antigen Fusion Proteins in Vivo. Cancer Res. 63: 1780-1788 [Abstract] [Full Text]  
  • Abdelhamed, A. M., Kelley, C. M., Miller, T. G., Furman, P. A., Cable, E. E., Isom, H. C. (2003). Comparison of Anti-Hepatitis B Virus Activities of Lamivudine and Clevudine by a Quantitative Assay. Antimicrob. Agents Chemother. 47: 324-336 [Abstract] [Full Text]  
  • Bacon, T. H., Levin, M. J., Leary, J. J., Sarisky, R. T., Sutton, D. (2003). Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy. Clin. Microbiol. Rev. 16: 114-128 [Abstract] [Full Text]  
  • Leary, J. J., Wittrock, R., Sarisky, R. T., Weinberg, A., Levin, M. J. (2002). Susceptibilities of Herpes Simplex Viruses to Penciclovir and Acyclovir in Eight Cell Lines. Antimicrob. Agents Chemother. 46: 762-768 [Abstract] [Full Text]  
  • Alauddin, M. M., Shahinian, A., Gordon, E. M., Bading, J. R., Conti, P. S. (2001). Preclinical Evaluation of the Penciclovir Analog 9-(4-[18F]Fluoro-3-Hydroxymethylbutyl)Guanine for In Vivo Measurement of Suicide Gene Expression with PET. JNM 42: 1682-1690 [Abstract] [Full Text]  
  • Vander Straten, M., Carrasco, D., Lee, P., Tyring, S. K. (2001). A Review of Antiviral Therapy for Herpes Labialis. Arch Dermatol 137: 1232-1235 [Full Text]  
  • Ng, T. I., Shi, Y., Huffaker, H. J., Kati, W., Liu, Y., Chen, C.-M., Lin, Z., Maring, C., Kohlbrenner, W. E., Molla, A. (2001). Selection and Characterization of Varicella-Zoster Virus Variants Resistant to (R)-9-[4-Hydroxy-2-(Hydroxymethy)Butyl]Guanine. Antimicrob. Agents Chemother. 45: 1629-1636 [Abstract] [Full Text]  
  • Sarisky, R. T., Quail, M. R., Clark, P. E., Nguyen, T. T., Halsey, W. S., Wittrock, R. J., Bartus, J. O'L., Van Horn, M. M., Sathe, G. M., Van Horn, S., Kelly, M. D., Bacon, T. H., Leary, J. J. (2001). Characterization of Herpes Simplex Viruses Selected in Culture for Resistance to Penciclovir or Acyclovir. J. Virol. 75: 1761-1769 [Abstract] [Full Text]  
  • Earnshaw, D. L., Pope, A. J. (2001). FlashPlate Scintillation Proximity Assays for Characterization and Screening of DNA Polymerase, Primase, and Helicase Activities. J Biomol Screen 6: 39-46 [Abstract]  
  • Thackray, A. M., Field, H. J. (2000). The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment. J. Gen. Virol. 81: 2385-2396 [Abstract] [Full Text]  
  • Sarisky, R. T., Nguyen, T. T., Duffy, K. E., Wittrock, R. J., Leary, J. J. (2000). Difference in Incidence of Spontaneous Mutations between Herpes Simplex Virus Types 1 and 2. Antimicrob. Agents Chemother. 44: 1524-1529 [Abstract] [Full Text]  
  • Thust, R., Tomicic, M., Klocking, R., Wutzler, P., Kaina, B. (2000). Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir. Mutagenesis 15: 177-184 [Abstract] [Full Text]  
  • Earnshaw, D. L., Moore, K. J., Greenwood, C. J., Djaballah, H., Jurewicz, A. J., Murray, K. J., Pope, A. J. (1999). Time-Resolved Fluorescence Energy Transfer DNA Helicase Assays for High Throughput Screening. J Biomol Screen 4: 239-248 [Abstract]  
  • Balfour, H. H. (1999). Antiviral Drugs. NEJM 340: 1255-1268 [Full Text]  
  • Yamanaka, G., Wilson, T., Innaimo, S., Bisacchi, G. S., Egli, P., Rinehart, J. K., Zahler, R., Colonno, R. J. (1999). Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus. Antimicrob. Agents Chemother. 43: 190-193 [Abstract] [Full Text]  
  • Ono, N., Iwayama, S., Suzuki, K., Sekiyama, T., Nakazawa, H., Tsuji, T., Okunishi, M., Daikoku, T., Nishiyama, Y. (1998). Mode of Action of (1'S,2'R)-9-{[1',2'-Bis(hydroxymethyl) cycloprop-1'-yl]methyl}guanine (A-5021) against Herpes Simplex Virus Type 1 and Type 2 and Varicella-Zoster Virus. Antimicrob. Agents Chemother. 42: 2095-2102 [Abstract] [Full Text]  
  • Thackray, A. M., Field, H. J. (1998). Famciclovir and Valaciclovir Differ in the Prevention of Herpes Simplex Virus Type 1 Latency in Mice: a Quantitative Study. Antimicrob. Agents Chemother. 42: 1555-1562 [Abstract] [Full Text]  
  • Iwayama, S., Ono, N., Ohmura, Y., Suzuki, K., Aoki, M., Nakazawa, H., Oikawa, M., Kato, T., Okunishi, M., Nishiyama, Y., Yamanishi, K. (1998). Antiherpesvirus Activities of (1'S,2'R)-9-{[1',2'-Bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine (A-5021) in Cell Culture. Antimicrob. Agents Chemother. 42: 1666-1670 [Abstract] [Full Text]  
  • Mertz, G. J., Loveless, M. O., Levin, M. J., Kraus, S. J., Fowler, S. L., Goade, D., Tyring, S. K. (1997). Oral Famciclovir for Suppression of Recurrent Genital Herpes Simplex Virus Infection in Women: A Multicenter, Double-Blind, Placebo-Controlled Trial. Arch Intern Med 157: 343-349 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»